Study shows risk of MIS-C post mRNA vaccination against COVID-19 in children with autoimmune complications
Researchers discuss two cases of MIS-V after the patients had received the SARS-CoV-2 vaccine from Pfizer/BioNTech (BNT162b2).
from News Medical Medical Research News Feed https://ift.tt/3r52qBu
0 Comments